Potensi Ekstrak Etanol Daun Keladi Tikus (Typhonium flagelliforme Lodd.) Sebagai Induktor Apoptosis Sel Kanker Lidah Manusia (SP-C1)
DOI:
https://doi.org/10.18196/di.v1i2.530Keywords:
apoptosis, cancer cell, Typhonium flagelliforme LoddAbstract
Typhonium flagelliforme Lodd has been used traditionally to cure breast cancer, lung, colon, rectum, liver, prostate, kidney, cervix, throat, bone, brain, spleen, bladder, leukimia and pancreas cancer. The ethanolic extract of Typhonium flagelliforme Lodd contained active compounds that could inhibit cancer cell growth. One of the active compounds was saponin and phenolic. The aim of study was to examine the potency ethanolic extract of Typhoniumflagelliforme Lodd. as inductor of apoptosis in human oral tongue cancer cell Supri's Clone-1 (SP-C1). The desingn of used in this study was pure laboratoris experimental with human oral tongue cancer cells line (SP-C1) as a sample which treated by ethanolic extract of Typhonium flagelliforme Lodd in various concentrations (0, 25, 50, 75, 100, 125 µg/ml) for 48 hours. Apoptosis examination was carrried out by painting with etidium bromide-acridin orange. The result of the study showed that etanolic exstract of Typhonium flagelliforme Lodd. induced apoptotic SP-C1 cell line. Statistical analisis with One Way Anova revealed etanolic extract in various concentration have significant differences (P=0,00) after treated with etanolic extract Typonium flagelliforme Lodd. It also found that the most effective concentration inducing apoptosis of human tongue cancer cells Supri's Clone-1 (SP-C1) was the 125 µg/mL. The conclusion of this research, ethanolic extract of Typhonium flagelliforme Lodd. has a potency to induce apoptosis human oral tongue cancer cells (SP-C1).
Downloads
Published
2012-07-15
Issue
Section
Articles
License
License
Insisiva Dental Journal : Majalah Kedokteran Gigi Insisiva (IDJ) is licensed under an Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially. This license is acceptable for Free Cultural Works.
The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Copyright
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under an Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
